CT45A10

Across TCGA pan-cancer cohorts, CT45A10 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of CT45A10’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where CT45A10 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types CT45A10 is over-expressed in tumor.

HNSC, BRCA, and LUSC are the cancer types where CT45A10 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CT45A10 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	Male	All	+1.205	.001	4	view →
BRCA	All	All	+0.028	.029	4	view →
LUSC	Male	All	+0.518	.039	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

CT45A10–HNSC

Open the HNSC breakdown →